Evaluation of NF2 gene deletion in pediatric meningiomas using chromogenic in situ hybridization

International Journal of Surgical Pathology

Volumn 15, Issue 2, 2007, Pages 110-115

  Begnami, Maria D ^a   Rushing, Elisabeth J ^b   Santi, Mariarita ^c   Quezado, Martha ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

CISH; Neurofibromatosis type II; NF2 gene; Pediatric meningioma

Indexed keywords

MERLIN; PARAFFIN;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; GENE DELETION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MENINGIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; CHILD; CHROMOGENIC COMPOUNDS; GENE DELETION; GENES, NEUROFIBROMATOSIS 2; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MENINGEAL NEOPLASMS; MENINGIOMA; NEUROFIBROMIN 2; TUMOR MARKERS, BIOLOGICAL;

EID: 34047261443     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896906299128     Document Type: Article

References (36)

1. CBTRUS. Statistical Report. Primary Brain Tumors in the United States, 1995-1999 Hinsdale, Ill: Central Brain Tumor Registry of the United States ; 2002.
2. Amirjamshidi A., Mehrazin M., Abbassioun K. Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature. Childs Nerv Syst. 2000 ; 16: 406-416. Review.
3. Baumgartner JE, Sorenson JM Meningioma in the pediatric population. J Neurooncol. 1996 ; 29: 223-228.
4. Ferrante L., Acqui M., Artico M., Mastronardi L., Rocchi G., Fortuna A. Cerebral meningiomas in children. Childs Nerv Syst. 1989 ; 5: 83-86.
5. Perry A., Dehner LP Meningeal tumors of childhood and infancy. An update and literature review. Brain Pathol. 2003 ; 13: 386-408.
6. Rushing EJ, Olsen C., Mena H., et al. Central Nervous System Meningiomas in the first two decades of life: Clinicopathologic analysis of 87 cases. J Neurosurg. 2005 ; 103: 489-495.
7. Erdincler P., Lena G., Sarioglu AC, Kuday C., Choux M. Intracranial meningiomas in children: review of 29 cases. Surg Neurol. 1998 ; 49: 136-140.
8. Di Rocco C, Di Rienzo A. Meningiomas in childhood. Crit Rev Neurosurg. 1999 ; 9: 180-188.
9. Ruttledge MH, Xie YG, Han FY, et al. Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer. 1994 ; 10: 122-130.
10. Leone PE, Bello MJ, de Campos JM, et al. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene. 1999 ; 18: 2231-2239.
11. Antinheimo J., Sankila R., Carpen O., Pukkala E., Sainio M., Jaaskelainen J. Population-based analysis of sporadic and NF-2 associated meningiomas and schwannomas. Neurology. 2000 ; 54: 71-76.
12. Perry A., Giannini C., Raghavan R., et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol. 2001 ; 60: 994-1003.
13. Louis DN, Ramesh V., Gusella JF Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol. 1995 ; 5: 163-172.
14. Antinheimo J., Haapasalo H., Haltia M., et al. Proliferation potential and histological features in neurofibromatosis 2-associated and sporadic meningiomas. J Neurosurg. 1997 ; 87: 610-614.
15. Lamszus K., Vahldiek F., Mautner VF, et al. Allelic losses in neurofibromatosis 2-associated meningiomas. J Neuropathol Exp Neurol. 2000 ; 59: 504-512.
16. Biegel JA, Parmiter AH, Sutton LN, Rorke LB, Emanuel BS Abnormalities of chromosome 22 in pediatric meningiomas. Genes Chromosomes Cancer. 1994 ; 9: 81-87.
17. Slavc I., MacCollin MM, Dunn M., et al. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer. 1995 ; 64: 243-247.
18. Al-Mefty O., Kadri PA, Pravdenkova S., Sawyer JR, Stangeby C., Husain M. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg. 2004 ; 101: 210-218.
19. Ghim TT, Seo JJ, O'Brien M., Meacham L., Crocker I., Krawiecki N. Childhood intracranial meningiomas after high-dose irradiation. Cancer. 1993 ; 71: 4091-4095.
20. Gold DG, Neglia JP, Dusenbery KE Second neoplasms after megavoltage radiation for pediatric tumors. Cancer. 2003 ; 97: 2588-2596.
21. Kantar M., Cetingul N., Kansoy S., et al. Radiotherapy-induced secondary cranial neoplasms in children. Childs Nerv Syst. 2004 ; 20: 46-49.
22. Moss SD, Rockswold GL, Chou SN, Yock D., Berger MS Radiation-induced meningiomas in pediatric patients. Neurosurgery. 1988 ; 22: 758-761.
23. Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med. 1991 ; 325: 1330-1336.
24. Rubinstein AB, Shalit MN, Cohen ML, Zandbank U., Reichenthal E. Radiation-induced cerebral meningioma: a recognizable entity. J Neurosurg. 1984 ; 61: 966-971.
25. Shoshan Y., Chernova O., Juen SS, et al. Radiation-induced meningioma: a distinct molecular genetic pattern? J Neuropathol Exp Neurol. 2000 ; 59: 614-620.
26. Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol. 2004 ; 63: 275-286.
27. Louis DN, Scheithauer BW, Budka H., von Deimling A., Keppes JJ Meningiomas. In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press ; 2000: 176-184.
28. Zwerdling T., Dothage J. Meningiomas in children and adolescents. J Pediatr Hematol Oncol. 2002 ; 24: 199-204.
29. Zankl H., Zang KD Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Humangenetik. 1972 ; 14: 167-169.
30. Li-Ning TE, Ronchetti R., Torres-Cabala C., Merino MJ Role of chromogenic in situ hybridization (CISH) in the evaluation of HER2 status in breast carcinoma: comparison with immunohistochemistry and FISH. Int J Surg Pathol. 2005 ; 13: 343-351.
31. Thorner PS, Ho M., Chilton-MacNeill S, Zielenska M. Use of chromogenic in situ hybridization to identify MYCN gene copy number in neuroblastoma using routine tissue sections. Am J Surg Pathol. 2006 ; 30: 635-642.
32. Quezado M., Ronchetti R., Rapkiewicz A., Santi M., Blumenthal DT, Rushing EJ Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM. Clin Neuropathol. 2005 ; 24: 163-169.
33. Tanner M., Gancberg D., Di Leo A., et al. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol. 2000 ; 157: 1467-1472.
34. Hitotsumatsu T., Iwaki T., Kitamoto T., et al. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study. Acta Neuropathol (Berl). 1997 ; 93: 225-232.
35. Pylkkanen L., Sarlomo-Rikala M., Wessman M., et al. Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors. Hum Pathol. 2003 ; 34: 872-879.
36. Mallucci CL, Parkes SE, Barber P., et al. Paediatric meningeal tumours. Childs Nerv Syst. 1996 ; 12: 582-588.